Kaplan–Meier survival analyses for serous, clear cell, endometrioid, and mucinous carcinomas revealed no statistically significant differences in DFS or OS according to the RBM3 expression status (Supplementary Figure S1). Here, RBM3 is linked to mucinous adenocarcinoma.